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1726-4Noninvasive diagnostic methods for Helicobacter pylori infectionHelicobacter pylori is one of the most frequently occurring
and persistent bacterial infections worldwide. H. pylori bac-
teria are associated with peptic ulcer disease, mucosa-
associated lymphoid tissue lymphoma, and gastric cancer.1
Various diagnostic methods are used to detect H. pylori
infection. However, only highly accurate tests with 90% sen-
sitivity and 90% specificity should be used in clinical practice.
Commonly, the invasive diagnostic methods include endos-
copy with histology, rapid urease test, bacterial culture, and
molecular method (such as polymerase chain reaction); the
noninvasive methods include serology, urea breath test, and
stool antigen test (SAT). The use of a saliva antigen or anti-
body test for H. pylori detection remains premature.2 Herein,
we briefly review these noninvasive diagnostic methods.
The 13 C-urea breath test (13C-UBT) is one of the most
reliable tests for diagnosing H. pylori infection. It is a simple,
noninvasive, and safe test that provides excellent accuracy
both for the initial diagnosis of H. pylori infection and for the
confirmation of its eradication.3 Posttreatment UBT is usually
performed 4e6 weeks after the eradication therapy. With the
most widely used protocol (75 mg of urea with citric acid),
excellent accuracy is obtained when breath samples are col-
lected as early as 15 minutes after urea ingestion. The 13C-
UBT in adults has a high sensitivity (88e95%) and specificity
(95e100%).4 However, the test has shown heterogeneous
accuracy in the pediatric population, especially in young
children.
The SAT is a noninvasive method used to detect H. pylori,
usually recommended when UBT is not available. This method
is especially relevant for children's access to a safe diagnosis.
There are two types of SATs used for H. pylori detection: the
enzyme immunoassay and an assay based on immunochroma-
tography. A meta-analysis revealed that the global sensitivity
and specificity of SATs are 94% and 97%, respectively.5
H. pylori SAT (easy One-Step Test, Firstep Bioresearch Inc.,
Tainan, Taiwan) was added to the fecal occult blood test used for
colorectal cancer screening in a program in Taiwan in order to
detect upper gastrointestinal (GI) lesions, mostly due to
H. pylori. The prevalence of upper GI lesions was higher in
those patients with a positiveH. pylori SAT than in those with a
positive guaiac-based test (34.6% vs. 24.7%).6
Detecting anti-H. pylori antibodies [immunoglobulin G
(IgG)] with enzyme-linked immunosorbent assay through
routine serology is recommended for initial screening,x.doi.org/10.1016/j.jcma.2014.11.001
901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Assrequiring further confirmation by histology and/or culture
prior to treatment. Serological tests have several advantages,
in that they are noninvasive and they do not produce false
negative results in patients receiving certain treatments (proton
pump inhibitors and antibiotics) or presenting with acute
bleeding. It also can detect specific H. pylori proteins (with
virulence factors such as Cag A, Vac A). One drawback is the
prolonged existence of antibodies in the host even after a
successful eradication therapy. This situation limits the utility
of serology in confirming the eradication of H. pylori. A recent
study with 29 different serological tests showed sensitivity
rates ranging from 55.6% to 100%, and specificity rates
ranging from 59.6% to 97.9 %.7
Detection of H. pylori in other specimens includes saliva,
subgingival biofilm, dental plaque, and gastric juice. The
ability to detect H. pylori antibodies in saliva is lower than in
blood-based serology. However, the use of molecular techni-
ques for the detection of H. pylori infection in saliva or dental
plaque may make these specimens attractive because they are
easier to collect. The prevalence of H. pylori in dental plaques
has been reported by several studies, with findings ranging
from 0% to 100%.8 This wide variation may be explained by
the characteristics of the different sample populations, differ-
ing sampling procedures, and differing methodologies used to
detect H. pylori in dental plaque. Compared with studies on
dental plaque, there are fewer reports on the prevalence of H.
pylori detection in saliva, and the majority of these studies
used either culture or polymerase chain reaction methods.
Ultimately, the detection rates in saliva were generally noted
to be less than those in dental plaque.8 This may be because as
a biofilm, dental plaque allows the bacteria to adhere to solid
surfaces, and the constant flow of saliva may contribute to a
reduction in bacterial load, making detection difficult. A study
detecting anti-H. pylori IgG by enzyme-linked immunosorbent
assay in India showed a 79% sensitivity and a 64% specificity,
with 75% accuracy.9 Another study detecting H. pylori saliva
antigen suggested that oral H. pylori infection continued to
persist even though gastric H. pylori was already cured (neg-
ative UBT).10 Yang et al's2 study, in this issue, showed that the
one-step H. pylori saliva antigen test exhibited a moderate
sensitivity (71%) but low specificity (55%). The detection of
H. pylori in saliva and dental plaque may precede or may be
independent of gastric infection. It is not yet clear whether the
presence of H. pylori in the oral cavity represents long-termociation. All rights reserved.
84 Editorial / Journal of the Chinese Medical Association 78 (2015) 83e84colonization or whether its presence is transient due to either
gastric reflux or because it is in route to the stomach.8
In conclusion, 13C-UBT is one of the most reliable tests for
diagnosing H. pylori infection, especially after eradication
therapy. The SAT method is recommended for children. It
could be combined with a stool occult blood test (enzyme
immunoassay) for upper GI screening and colorectal cancer
screening, respectively. However, additional study is necessary
to help determine the overall accuracy and clinical implica-
tions when H. Pylori is detected in saliva or dental plaques.
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